Yu Peng - Net Worth and Insider Trading

Yu Peng Net Worth

The estimated net worth of Yu Peng is at least $10 Million dollars as of 2024-06-23. Yu Peng is the Director of Henan Lingrui Pharmaceutical Co Ltd and owns about 400,000 shares of Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) stock worth over $10 Million. Details can be seen in Yu Peng's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Yu Peng has not made any transactions after 2021-07-29 and currently still holds the listed stock(s).

Transaction Summary of Yu Peng

To

Yu Peng Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Yu Peng owns 1 companies in total, including Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) .

Click here to see the complete history of Yu Peng’s form 4 insider trades.

Insider Ownership Summary of Yu Peng

Ticker Comapny Transaction Date Type of Owner
SHSE:600285 Henan Lingrui Pharmaceutical Co Ltd 2021-07-29 Director

Yu Peng Latest Holdings Summary

Yu Peng currently owns a total of 1 stock. Yu Peng owns 400,000 shares of Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) as of July 29, 2021, with a value of $10 Million.

Latest Holdings of Yu Peng

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SHSE:600285 Henan Lingrui Pharmaceutical Co Ltd 2021-07-29 400,000 24.30 9,720,000

Holding Weightings of Yu Peng


Yu Peng Form 4 Trading Tracker

According to the SEC Form 4 filings, Yu Peng has made a total of 1 transactions in Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Henan Lingrui Pharmaceutical Co Ltd is the sale of 400,000 shares on July 29, 2021, which brought Yu Peng around $2 Million.

Insider Trading History of Yu Peng

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Yu Peng Trading Performance

GuruFocus tracks the stock performance after each of Yu Peng's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Yu Peng is -3.05%. GuruFocus also compares Yu Peng's trading performance to market benchmark return within the same time period. The performance of stocks bought by Yu Peng within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Yu Peng's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Yu Peng

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
3 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -11.11 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -10.17 LIMIT LIMIT LIMIT LIMIT LIMIT

Yu Peng Ownership Network

Ownership Network List of Yu Peng

No Data

Ownership Network Relation of Yu Peng

Insider Network Chart

Yu Peng Owned Company Details

What does Henan Lingrui Pharmaceutical Co Ltd do?

Who are the key executives at Henan Lingrui Pharmaceutical Co Ltd?

Yu Peng is the Director of Henan Lingrui Pharmaceutical Co Ltd. Other key executives at Henan Lingrui Pharmaceutical Co Ltd include Supervisors Li Jin , senior management Ye Qiang , and Directors & senior managers Chen Yan .

Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) Insider Trades Summary

Over the past 18 months, Yu Peng made no insider transaction in Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285). Other recent insider transactions involving Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) include a net sale of 298,500 shares made by Wu Xi Zhen , and a net sale of 93,600 shares made by Li Jin .

In summary, during the past 3 months, insiders sold 186,100 shares of Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) in total and bought 0 shares, with a net sale of 186,100 shares. During the past 18 months, 392,100 shares of Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) were sold and 0 shares were bought by its insiders, resulting in a net sale of 392,100 shares.

Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Henan Lingrui Pharmaceutical Co Ltd Insider Transactions

No Available Data

Yu Peng Mailing Address

Above is the net worth, insider trading, and ownership report for Yu Peng. Currently GuruFocus does not have mailing address information for Yu Peng.

Discussions on Yu Peng

No discussions yet.